What Drug Supply Chain Security Act (DSCSA) - Enhanced Drug Distribution Security Requirements for Interoperable, Electronic Tracing of Products at the Package Level requires
The DSCSA requires all pharmaceutical trading partners to implement a fully electronic, interoperable system to trace and verify prescription drugs at the individual package level throughout the U.S. supply chain. As mandated by Section 582 of the FD&C Act, this includes exchanging secure transaction information (TI) and transaction statements (TS) for each product movement and verifying product identifiers upon request or for saleable returns.
Pillar: Medical & Healthcare · Authority: U.S. Food and Drug Administration (FDA) · Version: 1.0.0 · Last updated:
Primary source: https://www.fda.gov/drugs/drug-supply-chain-integrity/drug-supply-chain-security-act-dscsa
SHA-256 integrity: 16ddf80ce37881378d12b3166c8da19b966878f8bbaa9b1a90ec73d77007bb00
Primary Citations — 7 traced to source
- Federal Food, Drug, and Cosmetic Act, Section 582(g)(1): Enhanced Drug Distribution Security
- Federal Food, Drug, and Cosmetic Act, Section 582(b)(4): Manufacturer Requirements
+ 5 more citations (full bibliography, deterministic workflow, actionable schema and crosswalks) included in the vault unlock — $0.01 via Skyfire / L402 / Direct Base USDC.
Access
- Discovery (free): /api/v1/nodes/us-drug-supply-chain-security-act-2023-dscsa.json — 6-field metadata
- Vault (full node): /api/v1/vault/nodes/us-drug-supply-chain-security-act-2023-dscsa.json — full 13-key payload, $0.01 USDC (L402/Skyfire/Direct Base)
- Canonical URL: https://bidda.com/intelligence/us-drug-supply-chain-security-act-2023-dscsa
- Back to registry: Browse all 10,090 compliance nodes